RC
CELUW icon

RegentAtlantic Capital’s Celularity Inc CELUW Stock Holding History

RegentAtlantic Capital’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$9K Sell
24,000
-10,300
-30% -$4.47K ﹤0.01% 665
2022
Q2 		$20K Buy
+34,300
New +$33.8K ﹤0.01% 673

Other funds holding CELUW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

RegentAtlantic Capital's CELUW Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Celularity Inc (CELUW) stake by 30% in Q3 2022, selling an estimated $4.47K and leaving 24,000 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

RegentAtlantic Capital first reported a position in CELUW in Q2 2022 and has held it in 2 quarters since. The position peaked at $20K in Q2 2022. 22 funds tracked by Wall St. Rank hold CELUW as of Q3 2022.

  • RegentAtlantic Capital held 24,000 shares of Celularity Inc worth $9K as of Q3 2022.
  • RegentAtlantic Capital sold 10,300 Celularity Inc shares in Q3 2022, an estimated $4.47K.
  • Celularity Inc made up ﹤0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #665 holding.
  • RegentAtlantic Capital first reported a position in Celularity Inc in Q2 2022 and has held it in 2 quarters since.
  • RegentAtlantic Capital's Celularity Inc position peaked at $20K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Celularity Inc as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.